Copyright
©The Author(s) 2016.
World J Gastroenterol. May 7, 2016; 22(17): 4389-4396
Published online May 7, 2016. doi: 10.3748/wjg.v22.i17.4389
Published online May 7, 2016. doi: 10.3748/wjg.v22.i17.4389
Table 8 Adverse events, n
| Relation | Severity | AEs; |
| patients | ||
| (safety set) | ||
| None | Mild | 35; 12 (48%) |
| Moderate | 7; 4 (16%) | |
| Severe | 0; 0 (0%) | |
| Total | 42; 13 (52%) | |
| Possibly or definitely related | Mild | 15; 6 (24%) |
| Moderate | 6; 5 (20%) | |
| Severe | 0; 0 (0%) | |
| Total | 21; 8 (32%) |
- Citation: Ruuska T, Küster P, Grahnquist L, Lindgren F, Wewer AV. Efficacy and safety of granulocyte, monocyte/macrophage adsorptive in pediatric ulcerative colitis. World J Gastroenterol 2016; 22(17): 4389-4396
- URL: https://www.wjgnet.com/1007-9327/full/v22/i17/4389.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i17.4389